Sofinnova Investments, Inc. Astrazeneca PLC Transaction History

Sofinnova Investments, Inc.

$1.8 Billion
Q2 2024

A detailed history of Sofinnova Investments, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 801,417 shares of AZN stock, worth $66.6 Million. This represents 3.47% of its overall portfolio holdings.

Number of Shares

801,417

Previous 596,713 34.31%

Holding current value

$66.6 Million

Previous $40.4 Million 54.6%

% of portfolio

3.47%

Previous 2.35%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$66.81 - $80.83 $13.7 Million - $16.5 Million	204,704 Added 34.31%	801,417 $62.5 Million
Q1 2024 Aug 14, 2024	SELL	$61.03 - $69.57 $12.5 Million - $14.2 Million	-204,704 Reduced 25.54%	596,713 $40.4 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $15.5 Million - $17.7 Million	-253,864 Reduced 29.85%	596,713 $40.4 Million
Q4 2023 Aug 15, 2024	BUY	$61.89 - $69.28 $3.04 Million - $3.41 Million	49,160 Added 6.13%	850,577 $57.3 Million
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $52.4 Million - $58.7 Million	-846,940 Reduced 49.89%	850,577 $57.3 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $119 Million - $129 Million	1,697,517 New	1,697,517 $121 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $4.78 Million - $6.21 Million	-88,205 Reduced 12.57%	613,673 $41.6 Million
Q3 2022 Nov 08, 2022	BUY	$53.02 - $135.75 $20.4 Million - $52.3 Million	385,518 Added 121.86%	701,878 $38.5 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $14.1 Million - $16.9 Million	-237,543 Reduced 42.89%	316,360 $20.9 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $30.9 Million - $37.2 Million	553,903 New	553,903 $36.7 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $60.9 Million - $72 Million	-1,128,272 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $9.37 Million - $10.3 Million	168,640 Added 17.57%	1,128,272 $67.8 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $3.68 Million - $4.58 Million	-76,100 Reduced 7.35%	959,632 $57.5 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $9.11 Million - $10.5 Million	193,132 Added 22.92%	1,035,732 $51.5 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $40.9 Million - $48.9 Million	842,600 New	842,600 $42.1 Million
Q2 2019 Aug 13, 2019	SELL	$37.28 - $41.68 $9.75 Million - $10.9 Million	-261,577 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $1.94 Million - $2.36 Million	-54,751 Reduced 17.31%	261,577 $10.6 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $2.79 Million - $3.14 Million	75,720 Added 31.47%	316,328 $12 Million
Q3 2018 Nov 15, 2018	SELL	$34.76 - $39.72 $3.1 Million - $3.54 Million	-89,192 Reduced 27.04%	240,608 $9.52 Million
Q2 2018 Nov 15, 2018	BUY	$34.55 - $37.05 $10.2 Million - $11 Million	295,819 Added 870.54%	329,800 $11.6 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $419,747 - $450,120	12,149 Added 55.65%	33,981 $1.19 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $719,801 - $799,706	21,832 New	21,832 $763,000

Others Institutions Holding AZN

# of Institutions

1,331

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $257B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Account

Sofinnova Investments, Inc. Astrazeneca PLC Transaction History